This text is a part of your HHCN+ membership

Two years after Enhabit traders known as for a sale and the corporate started a strategic evaluate, the supplier has closed a deal to be bought to personal fairness agency Kinderhook Industries.

At $1.1 billion, the money transaction equates to $13.80 per share, with an implied a number of of roughly 10x over estimated 2026 earnings, in response to a be aware from Jefferies analysts. They imagine this could fulfill traders.

In an announcement emailed to me on Monday, Enhabit CEO Barb Jacobsmeyer emphasised that the corporate wouldn’t change its day-to-day operations or technique.

“Enhabit intends to proceed working because it does as we speak, with the identical management, technique and dedication to our workers and communities,” Jacobsmeyer wrote. “We don’t anticipate any materials adjustments to our each day operations, crew construction or the way in which we serve sufferers because of this transaction.”

Nonetheless, there’s one management change afoot: Jacobsmeyer introduced in August 2025 that she would step down in July 2026 or upon the appointment of her successor.

For sure, the corporate is about to enter a brand new chapter, however Jacobsmeyer’s feedback on a secure strategic route spotlight the progress Enhabit has made in stabilizing the corporate after its rocky begin, following its spin-off from Embody in 2022. The deal additionally highlights different business developments, together with the function of diversification – significantly the worth of a margin-protecting hospice service line – and the continued transition to value-based care.

On this week’s unique, members-only HHCN+ Replace, I share my predictions on what the Enhabit/Kinderhook deal means, with evaluation and key insights, together with:

– The short-term penalties for Enhabit

– Kinderhook’s background in dwelling care and value-based care

– What the deal predicts about dealmaking within the sector

Embodying a brand new possession mannequin

The sale will enable the corporate to dramatically enhance its value-based preparations, partnerships, expertise stack and acquisition development, in response to a dialog I had with Joe Widmar, director of mergers and acquisitions at West Monroe.

These efforts will not characterize a radical change within the firm’s enterprise mannequin, however it can improve the velocity at which the corporate can obtain these targets with out the burden of a public inventory market on its again.

Beginning with the ‘acquisitive development’ prospects, Kinderhook’s earlier involvement within the dwelling care sector paints an image of what we will count on with the Enhabit funding.

“We imagine in it deeply [the home health/hospice] mannequin, and our monitor report proves that,” says Michalik. “Dwelling well being has been a key space of ​​focus for Kinderhook for many years. The corporate has efficiently invested in and scaled a number of dwelling care platforms by specializing in scientific high quality, affected person expertise and doctor engagement.”

An instance of Kinderhook’s background in dwelling well being care is its funding in Florida-based Trilogy Dwelling Healthcare, which it bought to CenterWell Dwelling Well being in 2023. Whereas Kinderhook owned Trilogy, the supplier accomplished 9 add-on acquisitions and expanded its footprint to 11 workplaces.

“These investments, mixed with a number one administration crew, created the biggest impartial dwelling well being care supplier in Florida,” Kinderhook President Louis Aurelio stated in an announcement on the time of the sale.

With an preliminary funding on a a lot bigger scale – Enhabit has 249 dwelling care areas, to not point out 117 hospice areas – I count on Kinderhook’s push for scale to be fairly aggressive, though Michalik emphasised that the acquisition technique will stay “considerate.”

As I map out a future the place Enhabit pursues development with new enthusiasm, I have to take into account that Jacobsmeyer targeted on operational and strategic stability in her responses to me.

With new possession and a CEO transition underway, this may occasionally appear to be a time to embrace transformation greater than stability. However Widmar recommended to me that Jacobsmeyer’s resignation and sale to Kinderhook are doubtless a coordinated effort and a “pure evolution of the group” — that means the corporate has had loads of time to chart its course and management succession, making the steadiness Jacobsmeyer emphasised doable regardless of important change.

The actual fact that the corporate’s message emphasizes “stability” versus “turnaround” is a testomony to the progress Enhabit has made lately. When the strategic evaluate was accomplished in Might 2024, firm management introduced that Enhabit would proceed to function as a standalone firm.

“We imagine that macroeconomic headwinds, together with, amongst different issues, unsure regulatory developments together with Medicare reimbursement insurance policies throughout the healthcare business and an evolving antitrust panorama, a troublesome healthcare working atmosphere and persistently excessive rates of interest have in the end suppressed the alternatives for a transaction that might improve shareholder worth,” Leo Higdon, chairman of Enhabit’s board, stated in an announcement.

Uncertainty nonetheless exists relating to Medicare reimbursement, however CMS’ determination to considerably soften charge cuts in 2026 might have performed a significant function in paving the way in which for this deal. Potential patrons within the dwelling care house had doubtless been ready for “higher readability” on reimbursement prospects to shut offers, Jefferies’ be aware stated.

As well as, Enhabit is considerably much less uncovered to Medicare charge danger as we speak than prior to now, when roughly 80% of the corporate’s income was tied to fee-for-service funds. Rebalancing that accompanied the transition to make Medicare Benefit a bigger payer. To provide only one instance of how troublesome this course of was, Enhabit left its relationship with UnitedHealthcare in 2024 after months of negotiations failed to provide what Jacobsmeyer known as “acceptable charges.”

The transfer drew cheers from different business leaders, together with many who commented on the choice at HHCN’s FUTURE convention that yr.

Finally, Enhabit reached an settlement with UnitedHealth that Jacobsmeyer discovered acceptable, despite the fact that the association was not thought-about a “payer innovation contract,” as outlined by Enhabit. This refers to Enhabit’s push to enter into extra favorable MA contracts. Whereas there are a number of options of the innovation technique for payers, one key objective was contracts organized round episodic reimbursement and quality-based preparations versus per-visit charges.

Enhabit has had success with this technique. As of the primary quarter of 2025, 44% of non-Medicare visits occurred in payer innovation contracts.

As for the opposite headwinds Higdon cited in 2023, the rate of interest atmosphere has after all modified with the Federal Reserve’s three consecutive charge cuts final yr. And the antitrust atmosphere can be completely different now, as evidenced by UnitedHealth Group’s acquisition of Amedisys, which was challenged by the Biden administration’s Justice Division.

Penalties of deal making

Along with Kinderhook’s expertise with dwelling care, the corporate has in depth expertise with value-based care, which can doubtless be a prime precedence for the brand new model of Enhabit.

The give attention to different and value-based reimbursement preparations can be prone to be a key focus for different offers within the house.

“That is indicative of the place the broader M&A exercise goes, and the place the main focus of dwelling care platforms goes,” Widmar stated. “It has been round for some time… however you are seeing increasingly more platforms with economies of scale on value-based care and beginning to type partnerships that we would not essentially have seen prior to now between dwelling well being businesses and different supplier teams, different risk-bearing entities.”

These partnerships goal to cut back the general value of care, but in addition diversify dwelling care suppliers’ income streams, which is a necessary step for suppliers squeezed by Medicare dwelling care reimbursements.

“These platforms want to complement that or fill gaps in EBITDA that they’ve skilled as a result of payment cuts,” Widmar stated.

If we take into account this deal and Elara Caring’s latest strategic funding, we will get a reasonably good thought of ​​what traders need as we speak. Traders will prioritize firms with a major footprint, a number of service strains, expertise investments and a place to achieve different cost preparations. These options will likely be mirrored in offers over the following 18 months, Widmar says, as consolidation continues to happen at native and regional ranges.

Enhabit’s twin companies within the area of dwelling care and hospice undoubtedly additionally appealed to Kinderhook. Hospice companies proceed to “subsidize” dwelling care companies, Widmar stated — and apart from the engaging reimbursement potential, these companies assist construct a optimistic affected person expertise and preserve prices in examine.

Lastly, the Kinderhook deal might point out that the M&A panorama — particularly for offers involving giant suppliers — has shifted to personal fairness, after years of megadeals dominated by payers like United and Humana (NYSE: HUM).

“…Given the present pressures in managed care and elevated regulatory scrutiny surrounding vertical integration, we take into account a [payer] copper unlikely on this case,” the Jefferies analysts wrote.

Certainly, a bit posted as we speak on PE Hub made the case for the rise of personal fairness on this space, citing the Enhabit deal together with latest investments in dwelling care and hospice from Renovus Capital; Trive Capital and Coltala; Revelstoke; and Linden Capital.

The market is at an fascinating inflection level, which makes me all of the extra excited for our Capital + Technique Convention subsequent month. If you happen to’ll forgive me for ending this piece on a promotional be aware, I encourage anybody considering discussing these developments additional to benefit from your HHCN+ low cost on occasion registration; Merely enter the code hhcnplus throughout checkout to obtain 25% off. I hope to see many Plus members in Charlotte!